SUBSCRIBE
SUBSCRIBE
News   Business

Gilead Sciences, Inc. Announces Departure of Caroline Dorsa

January 21, 2008 | 
1 min read
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Caroline Dorsa has resigned from her position as Chief Financial Officer (CFO), a role she assumed in November 2007, to pursue another opportunity.
People
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Pictured: Entrance to Pfizer's office in Belgium
Mergers & acquisitions
Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition
September 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
Drug pricing
Novartis Looking for Constructive Ways To Bring Down Drug Costs in US
September 22, 2025
 · 
2 min read
 · 
Tristan Manalac
a hand with a lit match lighting another match
IPOs
MapLight Keeps Biopharma’s IPO Flame Alight To Advance Alzheimer’s, Schizophrenia Drugs
September 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of a blue jay flying away into the sunset
Gene therapy
Bye Bye Bluebird: Gene Therapy Biotech Emerges From Private Buyout With Rebrand
September 19, 2025
 · 
2 min read
 · 
Annalee Armstrong